Yukiko Sakai

Executive Officer; Group Chief Sustainability Officer · Daiichi Life Group

Insurance

Yukiko Sakai is Daiichi Life Group’s Executive Officer and Group Chief Sustainability Officer. A former McKinsey Partner, she brings experience in healthcare systems, public-sector consulting and the development of health and sustainability initiatives.

Last reviewed: Nov 10, 2026

Yukiko Sakai

Executive Summary

Yukiko Sakai is Daiichi Life Group’s Executive Officer and Group Chief Sustainability Officer. A former McKinsey Partner, she brings experience in healthcare systems, public-sector consulting and the development of health and sustainability initiatives.

Career Highlights

  • Became a McKinsey Partner in 2019.
  • Held a McKinsey Health Institute geographical leadership role from 2022.
  • Joined Daiichi’s sustainability leadership in 2025.

Professional Journey

Sakai joined McKinsey in April 2007, working in Tokyo and Frankfurt as a Business Analyst before becoming an Associate. Following business-school study, she worked as a Manager at education business Delta Studio from August 2012 to June 2013. She returned to McKinsey’s Tokyo office in July 2013.

She became an Engagement Manager in July 2014, Associate Partner in July 2016 and Partner in January 2019. Her healthcare consulting addressed growth, marketing and new-business development for healthcare and insurance companies, as well as work with public institutions. She also contributed to establishing the firm’s public-sector practice.

Her professional work included supervising the Japanese edition of McKinsey’s global COVID-19 insights in 2020. From June 2022, she held a geographical leadership role at the McKinsey Health Institute, whose work focuses on improving health and extending healthy lives. She also devoted more than a decade to recruiting, describing talent development and access to opportunities as reasons for that involvement.

Sakai left her McKinsey roles in September 2024 and joined Dai-ichi Life Holdings as an Adviser in March 2025. The following month, she became Executive Officer and Group Chief Sustainability Officer, initially also leading the Sustainability Unit.

The appointment brought together her healthcare background and sustainability-project experience with pharmaceutical companies and government agencies. She continues as the group sustainability chief, while the separate unit-head designation ended in the April 2026 organization.

Education

Sakai earned a BS in Biology from the University of Tokyo in 2007 and an MBA from Harvard Business School in 2012.

Philanthropy and Professional Service

Sakai serves as a Councilor of FALIA, the Foundation for the Advancement of Life & Insurance Around the World.